Invega Sustenna (paliperidone palmitate 1-month) Patient Assistance Program
Don’t let the high cost of brand monthly schizophrenia injection disrupt your mental health treatment. We help eligible patients access Invega Sustenna (paliperidone palmitate 1-month long-acting IM) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Invega Sustenna (paliperidone palmitate 1-month) is FDA-approved for schizophrenia and schizoaffective disorder in adults — monthly long-acting IM injection. The foundation of the paliperidone LAI family and often the first LAI for treatment initiation before extended-interval formulations (Invega Trinza 3-monthly, Invega Hafyera 6-monthly).
- Without assistance, Invega Sustenna costs commonly run approximately $1,600–$2,000 per monthly injection (~$20,000+ annually).
- Through AffordMyPrescriptions, qualifying patients can access Invega Sustenna for a flat $69.95 per month.
- Related paliperidone LAIs: Invega Trinza (3-monthly IM), Invega Hafyera (6-monthly IM). Related long-acting antipsychotics: Abilify Maintena, Aristada, Risperdal Consta, Zyprexa Relprevv, Uzedy, Perseris. Many oral antipsychotic generics widely available (risperidone, olanzapine, quetiapine, aripiprazole, paliperidone).
What is Invega Sustenna Prescription Assistance Program?
The Invega Sustenna Patient Assistance Program helps eligible patients access this monthly long-acting injectable at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Invega Sustenna PAP enrollment for a flat $69.95 per month — so you never face a gap in your Invega Sustenna schizophrenia therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Invega Sustenna enrollment — so you never face a gap in your monthly injectable schizophrenia therapy.
Pharmacy Price Comparison
- Without assistance, Invega Sustenna costs thousands per year. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic risperidone oral | ~$15/mo | Very cheap oral generic alt |
| Specialty pharmacy | ~$1,600/mo | Save substantially |
| Psychiatric clinic | ~$1,900/mo | Save substantially |
| Hospital pharmacy | ~$2,000/mo | Save substantially |
| 340B community mental health | ~$1,300/mo | Save substantially |
| Generic paliperidone oral | ~$50/mo | Cheap oral generic alt |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Invega Sustenna — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Invega Sustenna Prescription Program?
The Invega Sustenna Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Long-acting injectables address adherence — a major cause of relapse and hospitalization in schizophrenia. Community mental health centers often facilitate LAI programs.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Invega Sustenna assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Invega Sustenna is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Invega Sustenna:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $1,600–$2,000/mo even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Invega Sustenna assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Invega Sustenna Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Invega Sustenna:
Invega Sustenna is a monthly IM long-acting injectable paliperidone — the foundation of the Invega LAI family. It delivers stable paliperidone levels over 30 days, addressing the adherence challenges of daily oral antipsychotics.
How It Works:
Adherence to daily oral antipsychotic medications is a major challenge in schizophrenia — nonadherence drives relapse, hospitalization, and poor long-term outcomes. Long-acting injectable (LAI) antipsychotics ensure therapeutic drug levels for weeks to months, dramatically improving adherence. Paliperidone (the active metabolite of risperidone) blocks dopamine D2 and serotonin 5-HT2A receptors — an atypical antipsychotic. Paliperidone palmitate is the palmitate ester injected IM as a depot — sustained release over 30 days for Invega Sustenna. It requires initial loading doses (day 1 and day 8) followed by monthly maintenance, and can be transitioned to Invega Trinza (3-monthly) or Invega Hafyera (6-monthly) once stable.
Form and Use:
Invega Sustenna IM injection in the deltoid or gluteal muscle. Loading dose: 234 mg IM on day 1 and 156 mg IM on day 8 (both deltoid), then 39–234 mg IM monthly maintenance based on response. Cold storage until use. Given at a psychiatric clinic or community mental health center.
Generic Availability:
No generic Invega Sustenna. Related paliperidone LAIs: Invega Trinza (3-monthly IM), Invega Hafyera (6-monthly IM) — same molecule, extended intervals after stabilization. Related LAIs (all brand): Abilify Maintena (aripiprazole monthly IM), Aristada (aripiprazole lauroxil monthly IM), Risperdal Consta (risperidone every 2 weeks IM), Zyprexa Relprevv (olanzapine every 2 or 4 weeks IM — post-injection sedation/delirium risk), Uzedy (risperidone monthly or every 2 months SC), Perseris (risperidone monthly SC). Oral antipsychotics: risperidone, olanzapine, quetiapine, aripiprazole, paliperidone, ziprasidone (mostly generic — very cheap). NAMI, Schizophrenia and Related Disorders Alliance. Community mental health centers often provide LAI programs.
Warnings:
Increased mortality in elderly patients with dementia-related psychosis (boxed warning — not approved for this), neuroleptic malignant syndrome, tardive dyskinesia, metabolic effects (weight gain, dyslipidemia, hyperglycemia — atypical class effect), hyperprolactinemia (menstrual irregularities, gynecomastia, sexual dysfunction), orthostatic hypotension. Other: injection site reactions, sedation, akathisia, EPS. The long-acting nature means side effects may persist for weeks after the last dose. Psychiatric monitoring is essential.
FAQ (Frequently Asked Questions)
How much does Invega Sustenna cost without insurance?
$1,600–$2,000 per monthly injection at specialty pharmacies or psychiatric clinics ($20,000+ annually). Generic oral paliperidone is ~$50/month; generic oral risperidone $10–$20/month. The LAI advantage is adherence, not cost per month.
How is Invega Sustenna different from oral paliperidone or risperidone?
Paliperidone is the active metabolite of risperidone — same class. Oral formulations require daily pill-taking; nonadherence is a major cause of schizophrenia relapse. Invega Sustenna monthly IM injection guarantees therapeutic drug levels for 30 days — same medication, dramatically different adherence profile.
How does Invega Sustenna relate to Invega Trinza and Hafyera?
All three are paliperidone palmitate depot injections at different intervals. Invega Sustenna is monthly (the foundation and starting LAI). Invega Trinza (3-monthly) requires prior stabilization on Sustenna for 4+ months. Invega Hafyera (6-monthly) requires prior stabilization on Sustenna for 4+ months or Trinza for 1 dose cycle. Progressive interval extension as the patient is stable.
Why choose a long-acting injectable over oral?
Adherence — nonadherence to daily oral antipsychotics drives schizophrenia relapse, hospitalization, and poor outcomes. LAIs guarantee therapeutic drug levels for weeks. Growing evidence shows LAIs improve outcomes vs oral in appropriately selected patients — including many first-episode and early-course patients. Discuss with your psychiatrist.
What are Invega Sustenna side effects?
Standard atypical antipsychotic effects: weight gain, metabolic effects (dyslipidemia, hyperglycemia), hyperprolactinemia (menstrual irregularities, gynecomastia, sexual dysfunction), sedation, akathisia, EPS. Injection site reactions are common. The long-acting formulation means side effects may persist for weeks after the last dose.
Take Control of Your Medication Costs
Long-acting monthly injectable schizophrenia therapy transforms adherence and outcomes. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.